Analysis of the TGFβ Pathway in Ovarian Cancer
Author Information
Author(s): Francis-Thickpenny K M, Richardson D M, Ee C C van, Love D R, Winship I M, Baguley B C, Chenevix-Trench G, Shelling A N
Primary Institution: Department of Obstetrics and Gynaecology, Research Centre in Reproductive Medicine, National Women’s Hospital, Auckland
Hypothesis
Somatic loss-of-function mutations in IGFIIR, TGFβ1, and TGFβRII disrupt the TGFβ growth inhibitory pathway in epithelial ovarian carcinoma.
Conclusion
The study found mutations in the TGFβRII gene in some ovarian carcinomas, suggesting distinct pathways for different cancer subtypes.
Supporting Evidence
- Three somatic missense mutations were found in the TGFβRII gene.
- No mutations were found in IGFRII or TGFβ1.
- An association was found between TGFβRII mutations and histology.
Takeaway
Researchers looked at genes related to ovarian cancer and found some changes in one gene that might help explain how different types of this cancer develop.
Methodology
Single-stranded conformational polymorphism analysis and DNA sequence analysis were used to examine the genes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website